-
First treatment for patients with rare lung disease approved
europeanpharmaceuticalreview
September 10, 2019
The FDA has approved the first treatment for interstitial lung disease associated with systemic sclerosis or scleroderma.
-
Gout May Up Risk for Progression of Chronic Kidney Disease
drugs
September 10, 2019
Gout is associated with an elevated risk for chronic kidney disease (CKD) progression, according to a study published online in BMJ Open.
-
Less TV, More Activity May Mean Extra Years Free of Heart Disease and Stroke
drugs
September 10, 2019
People who watch less TV and are physically active live more years free of heart disease, according to a new study.
-
Diabetes Control Has Stalled Across U.S.
drugs
September 09, 2019
U.S. adults with diabetes are no more likely to meet disease control targets than they were in 2005, a new study finds.
-
Inhibrx Announces Enrollment of First Patient in INBRX-101 Study
americanpharmaceuticalreview
September 06, 2019
Inhibrx announced the enrollment of the first patient in a Phase 1 clinical trial of INBRX-101. INBRX-101 is an Fc-fusion protein-based therapeutic candidate comprised of a modified recombinant version...
-
Drinking More Coffee Tied to Lower Risk for Gallstone Disease
drugs
September 06, 2019
Individuals who drink more than six cups of coffee per day have a reduced risk for developing symptomatic gallstone disease (GSD), according to a study published online in the Journal of Internal Medicine.
-
Brain disease drug delivery platform developed by researchers
europeanpharmaceuticalreview
September 05, 2019
So-called ‘nanodiamonds’ could serve as a platform for diagnostic and therapeutic approaches for neurodegenerative diseases.
-
AstraZeneca’s SLE drug performs well in Phase III trial
pharmaceutical-technology
September 03, 2019
AstraZeneca has announced anifrolumab met the primary endpoint of the Phase III Tulip trial studying 373 systemic lupus erythematosus (SLE) patients.
-
Lifestyle May Matter More Than Your Genes in Early Heart Disease
drugs
September 03, 2019
An unhealthy lifestyle is a bigger contributor to heart disease than genetics for many younger adults, according to a new study.
-
Cerebrovascular Risk Factors May Up Risk for Parkinson Disease
drugs
September 02, 2019
Most cerebrovascular risk factors are associated with an increased risk for subsequent diagnosis of Parkinson disease...